A recent study by CU Medicine revealed a worrying fact that 40% of Hong Kong people appeared to have significant gut dysbiosis comparable to that of COVID-19 patients, suggesting they have potentially impaired immunity. CU Medicine has developed a microbiome immunity formula that targets gut dysbiosis. Compared with patients who had standard care, the research team found that more COVID-19 patients who received the microbiome immunity formula achieved complete symptom resolution, showed significantly reduced proinflammatory markers in their blood, had increased favourable bacteria in their stool; and developed neutralising antibody. Data also suggested that the formula can restore the balance of gut microbiota and boosts immunity.  

From right: Professor Francis CHAN, Dean of Medicine and Director of the Centre for Gut Microbiota Research; Professor Siew NG, Associate Director of the Centre for Gut Microbiota Research; and Dr. Joyce MAK, Assistant Professor of the Division of Gastroenterology and Hepatology at the Department of Medicine and Therapeutics; CU Medicine.